-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Context Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2020 to Q3 2025.
- Context Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$9,693,237.000, a 44.5% increase year-over-year.
- Context Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$26,440,916.000, a 12.3% increase year-over-year.
- Context Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$26,725,104.000, a 11.5% decline from 2023.
- Context Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$23,964,211.000, a 61.5% decline from 2022.
- Context Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$14,835,939.000, a 41.9% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)